List of SBIR/STTR awards granted to APT Therapeutics

where

SBIR/STTR Award Recipient

APT Therapeutics

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ APT THERAPEUTICS, INC. SBIR Phase II Award, April 2017	A SBIR Phase II contract was awarded to APT Therapeutics in April, 2017 for $1,902,274.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R44HL135993-01	Phase II	1,902,274	April 18, 2017	sbir.gov/node/1692303
‌ APT THERAPEUTICS, INC. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to APT Therapeutics in September, 2021 for $996,399.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	2R44NS106850-02	Phase II	996,399	September 20, 2021	sbir.gov/node/2192243
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2020	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43DK126493-01A1	Phase I	300,000	September 15, 2020	sbir.gov/node/1916831
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2019 for $344,933.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43NS113641-01	Phase I	344,933	September 15, 2019	sbir.gov/node/1683331
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2018 for $337,602.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43HL140699-01A1	Phase I	337,602	September 1, 2018	sbir.gov/node/1573603
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2018 for $299,346.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43NS106850-01	Phase I	299,346	September 1, 2018	sbir.gov/node/1566529
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, June 2021	A SBIR Phase I contract was awarded to APT Therapeutics in June, 2021 for $259,576.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43AR079294-01	Phase I	259,576	June 5, 2021	sbir.gov/node/2186775
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, April 2018	A SBIR Phase I contract was awarded to APT Therapeutics in April, 2018 for $299,794.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43CA228319-01	Phase I	299,794	April 16, 2018	sbir.gov/node/1566511
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	APT Therapeutics	National Institutes of Health	SBIR	1R43CA246779-01	Phase I	300,000	September 18, 2019	sbir.gov/node/1685927
‌ APT THERAPEUTICS, INC. SBIR Phase II Award, August 2016	A SBIR Phase II contract was awarded to APT Therapeutics in August, 2016 for $2,999,301.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	2SB1NS060175-04	Phase II	2,999,301	August 1, 2016	sbir.gov/node/1199495
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, August 2016	A SBIR Phase I contract was awarded to APT Therapeutics in August, 2016 for $2,736,786.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	2SB1NS060175-04	Phase I	2,736,786	August 1, 2016	sbir.gov/node/1324937
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2015	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2015 for $298,486.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43DK108315-01	Phase I	298,486	September 20, 2015	sbir.gov/node/1030477
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, May 2016	A SBIR Phase I contract was awarded to APT Therapeutics in May, 2016 for $299,200.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43DK109749-01	Phase I	299,200	May 1, 2016	sbir.gov/node/1163837
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2016	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43AR070662-01A1	Phase I	225,000	September 14, 2016	sbir.gov/node/1196939
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2017	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2017 for $279,040.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43DK113815-01	Phase I	279,040	September 15, 2017	sbir.gov/node/1322957
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, April 2017	A SBIR Phase I contract was awarded to APT Therapeutics in April, 2017 for $300,437.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R44HL135993-01	Phase I	300,437	April 18, 2017	sbir.gov/node/1306379
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, August 2015	A SBIR Phase I contract was awarded to APT Therapeutics in August, 2015 for $299,793.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43NS093684-01	Phase I	299,793	August 1, 2015	sbir.gov/node/1045771
‌ APT THERAPEUTICS, INC. SBIR Phase I Award, September 2015	A SBIR Phase I contract was awarded to APT Therapeutics in September, 2015 for $297,410.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43HL126212-01	Phase I	297,410	September 1, 2015	sbir.gov/node/1030715
‌ APT THERAPEUTICS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to APT Therapeutics for $1,307,456.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	2R44HL095169-02	Phase II	1,307,456		sbir.gov/node/389321
‌ APT THERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to APT Therapeutics for $287,622.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43NS071655-01	Phase I	287,622		sbir.gov/node/1897
‌ APT THERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to APT Therapeutics for $288,298.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43CA180165-01	Phase I	288,298		sbir.gov/node/677668
‌ APT THERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to APT Therapeutics for $281,598.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43HL115860-01	Phase I	281,598		sbir.gov/node/400862
‌ APT THERAPEUTICS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to APT Therapeutics for $1,107,150.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	2R44NS060175-02A1	Phase II	1,107,150		sbir.gov/node/1895
‌ APT THERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to APT Therapeutics for $189,572.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43HL087456-01	Phase I	189,572		sbir.gov/content/apyrase-treat-ischemiareperfusion-injury-during-lung-transplantation-0
‌ APT THERAPEUTICS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to APT Therapeutics for $98,750.0 USD from the U.S. Department of Health & Human Services.	APT Therapeutics		SBIR	1R43HL076053-01	Phase I	98,750		sbir.gov/content/production-human-cd39-antithrombotic-agent-0

Results per page:

33 results

0 selected

33 results

0 selected